Evidence map›Paper›PMID 37953877›Full record

ArticleFrontiers in molecular neuroscience2023

Transcriptional and bioinformatic analysis of GABA

Berenice A Gutierrez, José Manuel González-Coronel, Rogelio O Arellano, Agenor Limon

Open access · goldAbstract read
In one paragraph

Article in Frontiers in molecular neuroscience, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.8field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Berenice A GutierrezDepartment of Neurology, Mitchell Center for Neurodegenerative Diseases, University of Texas Medical Branch, Galveston, TX, United States.
José Manuel González-CoronelLaboratorio de Neurofisiología Celular, Instituto de Neurobiología, Universidad Nacional Autónoma de México, Juriquilla, Mexico.
Rogelio O ArellanoLaboratorio de Neurofisiología Celular, Instituto de Neurobiología, Universidad Nacional Autónoma de México, Juriquilla, Mexico.
Agenor LimonDepartment of Neurology, Mitchell Center for Neurodegenerative Diseases, University of Texas Medical Branch, Galveston, TX, United States.
The University of Texas Medical Branch at Galveston · USUniversidad Nacional Autónoma de México · MX

Funding

Mechanisms of Synaptic Protection in Cognitive Resilence to Alzheimer's Disease NeuropathologyR01AG070255 · NIA · UNIVERSITY OF TEXAS MED BR GALVESTON · PI LIMON, AGENOR · 2021 to 2025
$2.2M
NIA NIH HHS R01 AG070255
6 · The paper itself

Abstract

Introduction: Oligodendrocyte progenitor cells (OPCs) are vital for neuronal myelination and remyelination in the central nervous system. While the molecular mechanisms involved in OPCs' differentiation and maturation are not completely understood, GABA is known to positively influence these processes through the activation of GABA Methods: In this study, we conducted a transcriptomic analysis to investigate the molecular stoichiometry of GABA Results: Our analysis indicated that the most expressed subunits in OPCs are α1-3, β1-3, γ1-3, and ε. Moreover, we determined that the combination of any α with β2 and γ2 is likely to form heteropentameric GABA Discussion: This study presents the first transcriptional-level identification of GABA

Indexed as

fractional contributionGABA receptoroligodendrocyteOPCPDGFRARNA-sequencingsingle cellsingle nucleus

Identifiers

PMID37953877
PMCPMC10637375
OpenAlexW4388204203

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.